Sánchez-Pujol M J, Docampo Simón A, Illán Gambín F, Niveiro de Jaime M, Blanes Martínez M
Servicio de Dermatología, Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, España.
Servicio de Dermatología, Hospital General Universitario de Alicante. Instituto de Investigación Sanitaria y Biomédica de Alicante, Alicante, España.
Actas Dermosifiliogr (Engl Ed). 2021 Apr 30. doi: 10.1016/j.ad.2020.08.014.
Recent years have seen important advances in our understanding of calciphylaxis, especially regarding newly identified risk factors and histologic findings that may aid diagnosis. This retrospective study of cases of calciphylaxis treated in our hospital in the last 13 years focuses on newly revealed aspects of this disease. We describe 16 patients (62.5% women; mean age, 67.9 years). In addition to advanced kidney disease (in 75% of our patients), other factors associated with the presence of calciphylaxis were a history of treatments related to phosphorus and calcium metabolism (75%) and anticoagulation (62.5%), usually with vitamin-K antagonists. Histology showed alterations in elastic fibers in only 25% of the biopsy specimens. Eleven of the patients died: sepsis was most often the cause.
近年来,我们对钙过敏症的认识取得了重要进展,特别是在新发现的风险因素以及有助于诊断的组织学发现方面。这项对我院过去13年治疗的钙过敏症病例的回顾性研究聚焦于该疾病新发现的方面。我们描述了16例患者(女性占62.5%;平均年龄67.9岁)。除了晚期肾病(在我们75%的患者中存在)外,与钙过敏症存在相关的其他因素包括与磷和钙代谢相关的治疗史(75%)以及抗凝治疗史(62.5%),抗凝治疗通常使用维生素K拮抗剂。组织学检查显示仅25%的活检标本中弹性纤维有改变。11例患者死亡:败血症是最常见的死因。